Myriad Genetics Non-GAAP EPS of $0.04 beats by $0.06, revenue of $209.8M beats by $2.24M
Source: SeekingAlpha
2026-02-23 16:14:28 ET
More on Myriad Genetics
- Myriad Genetics, Inc. (MYGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Myriad Genetics, Inc. (MYGN) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Myriad Genetics Q4 2025 Earnings Preview
- Myriad Genetics partners to use AI to measure breast cancer risk
- Seeking Alpha’s Quant Rating on Myriad Genetics
Read the full article on Seeking Alpha
For further details see:
Myriad Genetics Non-GAAP EPS of $0.04 beats by $0.06, revenue of $209.8M beats by $2.24M
Myriad Genetics Inc.
NASDAQ: MYGN
MYGN Trading
6.63% G/L:
$5.145 Last:
1,279,277 Volume:
$5.18 Open:
MYGN Latest News
March 06, 2026 06:39:00 pm
Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
March 02, 2026 04:05:00 pm
Myriad Commercially Launches Precise MRD with Select Community Oncologists
MYGN Stock Data
$480,516,737
90,976,593
0.49%
72
N/A
Medical Diagnostics & Screening
Healthcare
US
Salt Lake City
